The Alzheimer’s Disease Diagnostic Market segment includes imaging techniques like MRI, CT, and PET, as well as biomarker-based and genetic tests. Imaging dominates due to its accuracy in identifying brain abnormalities.

End-user segmentation highlights hospitals, diagnostic centers, and research institutes as major users. Each segment contributes differently, with research facilities pushing innovation while clinics provide direct patient services.

FAQs
Q1. Which diagnostic method dominates the market segment?
A1. Imaging techniques such as MRI and PET scans dominate the segment.
Q2. Who are the main end-users of diagnostic tools?
A2. Hospitals, diagnostic labs, and research institutions are the primary users.